Drugs / Urapidil
Urapidil
Trials 8 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 34 trials | ||||||
| Phase 3 | NCT06863558 | May 2025 → Mar 2026 overdue | intracerebral hemorrhage | Second Affiliated Hospital, School of Medicine, Zhejiang University | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT06863571 | Apr 2025 → Mar 2026 overdue | ischemic stroke | Second Affiliated Hospital, School of Medicine, Zhejiang University | Recruiting | No outcome recorded |
| Phase 3 | NCT03790800 | Mar 2020 → Nov 2023 | stroke disorder | The George Institute for Global Health, China | Completed | No outcome recorded |
| Phase 3 | NCT02558023 | Sep 2015 → Aug 2020 | preeclampsia | University Hospital, Strasbourg, France | Terminated | No outcome recorded |
| Phase not applicable4 trials | ||||||
| — | NCT03497351 | Apr 2018 → Jan 2019 | — | Chinese PLA General Hospital | Completed | No outcome recorded |
| — | NCT03207100 | Dec 2017 → Feb 2021 | — | Hong Yang | Completed | No outcome recorded |
| — | NCT02116868 | Mar 2014 → Mar 2018 | — | Central Hospital, Nancy, France | Completed | No outcome recorded |
| — | NCT01311414 | — | brain ischemia | University Hospital Schleswig-Holstein | Withdrawn | No outcome recorded |
Also used as a comparator or background therapy in 10 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03001739 Background | Dec 2016 → Dec 2018 | aortic disorder, hypertensive disorder | Sir Run Run Shaw Hospital | Unknown | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT05670028 Background | Jun 2023 → Jan 2026 | ischemic stroke, vascular insufficiency disorder | Beijing Tiantan Hospital | Unknown | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT06677970 Comparator | Oct 2024 → Dec 2029 expected | ischemic stroke | Yonsei University | Recruiting | No outcome recorded |
| Phase 3 | NCT00409253 Comparator | Jun 2007 → Jun 2010 | preeclampsia | University Hospital, Strasbourg, France | Unknown | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT03529149 Background | Apr 2018 → Jun 2019 | ischemic stroke | Xuanwu Hospital, Beijing | Unknown | No outcome recorded |
| Phase 4 | NCT03300479 Comparator | Jun 2017 → May 2021 | intracerebral hemorrhage | University of Zurich | Withdrawn | No outcome recorded |
| Phase not applicable4 trials | ||||||
| — | NCT06609993 Background | Dec 2017 → Mar 2020 | abdominal aortic aneurysm | Michał Stasiowski | Completed | No outcome recorded |
| — | NCT02857153 Background | Jul 2016 → Jul 2017 | delirium | Hu Anmin | Unknown | No outcome recorded |
| — | NCT04500249 Background | Oct 2015 → Oct 2020 | carotid stenosis | Medical University of Silesia | Unknown | No outcome recorded |
| — | NCT00226096 Background | Nov 2005 → Sep 2007 | intracerebral hemorrhage | The George Institute | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 19 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Urapidil | “To manipulate the blood pressure within a certain range with hypotensive drugs (e.g. nifedipine, benidipine, captopril, benazepril, irbesartan, labetalol, urapidil) and/or...” NCT05670028 ↗17“Terazosin (no less than 1 mg orally or via nasogastric tube, nightly) or Urapidil (100 mg in 30 mL saline, IV infusion at no less than 2 mL/h)” NCT06863558 ↗ “rescue intravenous antihypertensive medication using 10 mcg of urapidil will be administered by anaesthesiologist” NCT04500249 ↗ “Urapidil (100 mg in 30 mL saline, IV infusion at no less than 2 mL/h)” NCT06863571 ↗ “Urapidil, nicardipine, and labetalol will be used in this group.” NCT03207100 ↗ “Urapidil” NCT02116868 ↗ |
| Known as | Ebrantil | ChEMBL registry synonym — accepted as the source's own label CHEMBL279229 ↗ |
| Known as | Ebrantil 25 | “urapidil (Ebrantil 25, Takeda PHARMA, Japan) in a dose of 10 mg will be administered intravenously” NCT06609993 ↗ |
| Known as | EUPRESSYL* | “Urapidil (Eupressyl\*) : IV One initial iv bolus of 12.5 mg.” NCT02558023 ↗1“URAPIDIL (EUPRESSYL*)” NCT00409253 ↗ |
| Known as | NSC-310405 | ChEMBL registry synonym — accepted as the source's own label CHEMBL279229 ↗ |
| Known as | URAPIDIL HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL279229 ↗ |
| Modality | Small molecule | — CHEMBL279229 ↗ |
| Route | Intravenous | “Urapidil (Eupressyl*) :IV” NCT00409253 ↗ |